Issue
Alert me when new journal issues are available via or via
Aims & scope/editorial board page iii Full-Text PDF (33 KB)
Preface Neil Blumberg, Charles W. Francis, Joanna M. Heal pages 1-2 Full Text | Full-Text PDF (36 KB)
1
Use of intravenous immunoglobulin G (IVIG) R. John Looney, Jennifer Huggins pages 3-25 Abstract | Full Text | Full-Text PDF (190 KB)
2
Rh-immunoglobulin: Rh prophylaxis John Bowman pages 27-34 Full Text | Full-Text PDF (91 KB)
3
Clinical uses of plasma and plasma fractions: plasma-derived products for hemophilias A and B, and for von Willebrand disease Cassandra D. Josephson, Thomas C. Abshire pages 35-49 Abstract | Full Text | Full-Text PDF (138 KB)
4
Management of factor VIII inhibitors Suchitra S. Acharya, Donna M. DiMichele pages 51-66 Abstract | Full Text | Full-Text PDF (195 KB)
5
Appraisal of the evidence for the clinical use of FFP and plasma fractions S.J. Stanworth, S.J. Brunskill, C.J. Hyde, M.F. Murphy, D.B.L. McClelland pages 67-82 Abstract | Full Text | Full-Text PDF (182 KB)
6
Clinical use of plasma and plasma fractions Richard K. Spence pages 83-96 Abstract | Full Text | Full-Text PDF (138 KB)
7
Plasma and plasma products in the treatment of massive haemorrhage Wendy N. Erber, David J. Perry pages 97-112 Abstract | Full Text | Full-Text PDF (153 KB)
8
Treating coagulopathy in liver disease with plasma transfusions or recombinant factor VIIa: an evidence-based review Glenn Ramsey pages 113-126 Abstract | Full Text | Full-Text PDF (136 KB)
9
Plasma and plasma components in the management of disseminated intravascular coagulation Marcel Levi, Evert de Jonge, Tom van der Poll pages 127-142 Abstract | Full Text | Full-Text PDF (181 KB)
10
Pediatric hemostasis and use of plasma components Neil A. Goldenberg, Marilyn J. Manco-Johnson pages 143-155 Abstract | Full Text | Full-Text PDF (124 KB)
11
Therapeutic apheresis: use of human serum albumin, fresh frozen plasma and cryosupernatant plasma in therapeutic plasma exchange Bruce C. McLeod pages 157-167 Abstract | Full Text | Full-Text PDF (110 KB)
12
Risks and side effects of therapy with plasma and plasma fractions Sheila MacLennan, John A.J. Barbara pages 169-189 Abstract | Full Text | Full-Text PDF (294 KB)
13
Fibrin glues of human origin Mauro Valbonesi pages 191-203 Abstract | Full Text | Full-Text PDF (128 KB)
14
Pathogen inactivation techniques J.P.R. Pelletier, S. Transue, E.L. Snyder pages 205-242 Abstract | Full Text | Full-Text PDF (903 KB)
15
Plasma protein therapies: current and future perspectives Albert Farrugia, Patrick Robert pages 243-258 Abstract | Full Text | Full-Text PDF (174 KB)
Subject Index for 19/1 pages I-VI Full-Text PDF (83 KB)
Copyright © 2010 Elsevier, Inc. All rights reserved | Privacy Policy | Terms & Conditions | Feedback | About Us | Help | Contact Us | The content on this site is intended for health professionals.
